News

BlinkLab lands $819K Australian tax refund for autism diagnostic work

What's the deal? BlinkLabDealroom has a profile for this one. Try Dealroom → received a US$789.2K (roughly $819,000) non-dilutive refund from the Australian Government's Research and Development Tax Incentive program, announced November 19, 2026. The money covers eligible R&D spending across the company's US pilot study, the launch of its US pivotal study, and Australian clinical research.

What's BlinkLab building? The company develops BlinkLab Dx1, a smartphone-based diagnostic aid for autism. It uses artificial intelligence and machine learning to capture objective, reflex-based metrics, aiming to shorten the long waits families face for specialist assessment.

In the US, roughly 1 in 31 children is diagnosed with autism, according to the company. BlinkLab was founded by neuroscientists from Princeton University.

Where the money goes: BlinkLab said the funds will support its US pivotal study, a planned FDA submission, and ongoing Australian clinical research, including the MAGNET study partnership with Monash University. The refund supplements a US$10.5M cash balance reported at the end of the September 2026 quarter.

Why now? The refund arrives as BlinkLab pushes toward its key regulatory milestone. The company said it is well capitalised to complete the US pivotal study and file with the FDA, with submission expected in the first quarter of 2027.

Keep it in proportion: The tax refund is modest next to the company's broader financing, which includes a US$11.3M share placement to fund the pivotal US study and regulatory work. The real value driver is whether the trial validates the diagnostic tool — not the refund itself.

The signal: Government R&D incentives remain a useful non-dilutive lever for clinical-stage startups bridging to major regulatory events. For BlinkLab, the refund is background support; the FDA submission is the story to watch.

Read more: kalkinemedia.com

Image credit: "Doctor examines child during a routine checkup in a bright, welcoming clinic environment with cheerful interactions" by nenad53, licensed under CC BY 2.0

More top stories